β-Nicotinamide mononucleotide, reduced form (disodium), CAS 108347-85-9

β-Nicotinamide mononucleotide, reduced form (disodium), CAS 108347-85-9
SKU
MEXHY-W615108B-100
Packaging Unit
100 mg
Manufacturer
MedChemExpress

Availability: loading...
Price is loading...
Product Description: β-Nicotinamide mononucleotide, reduced form disodium (β-NMN) is the oxidized form of NAD+ precursor and is a NAD+ enhancer. β-Nicotinamide mononucleotide, reduced form disodium can be reduced to dihydronicotinamide mononucleotide (NMNH). NMNH inhibits glycolysis, TCA cycle, and cell growth[1].

Applications: Cancer-programmed cell death

Formula: C11H15N2Na2O8P

References: [1]Liu Y, et al. Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth. J Proteome Res. 2021 May 7;20(5):2596-2606.

CAS Number: 108347-85-9

Molecular Weight: 380.20

Compound Purity: 98.0

Research Area: cancer

Solubility: H2O : 125 mg/mL (ultrasonic)

Target: Endogenous Metabolite
More Information
SKU MEXHY-W615108B-100
Manufacturer MedChemExpress
Manufacturer SKU HY-W615108B-100
Package Unit 100 mg
Quantity Unit STK
Product information (PDF) Download
MSDS (PDF) Download